Insiders · Profile

DAVE KAUSHIK J

CEO and Interim CFO at Actinium Pharmaceuticals. Filing since 14 Apr 2016. CIK 0001522751

Company

Date

Role

Action

Shares

Amount

Of holding

ATNM Actinium Pharmaceuticals, Inc.

14 Apr 2016

CEO and Interim CFO

Bought

10,000

$20.18K

12.7%

1 decision on file.